outcomes of microcoaxial cataract surgery using 1.8mm versus 2.2mm corneal incision
DESCRIPTION
Outcomes of Microcoaxial Cataract Surgery using 1.8mm versus 2.2mm Corneal Incision. The authors have no financial interest. Jung Hwa Na M.D. Eun Chul Kim M.D. Department of Ophthalmology and Visual Science, The Catholic University of Korea. Purpose. - PowerPoint PPT PresentationTRANSCRIPT
Outcomes of Microcoaxial Cataract Surgery using 1.8mm versus 2.2mm Corneal Incision
The authors have no financial interest
Jung Hwa Na M.D. Eun Chul Kim M.D.
Department of Ophthalmology and Visual Science, The Catholic University of Korea
Purpose
• To compare the postoperative results of microcoaxial cataract surgery (MCCS) using 1.8mm incision (Stellaris Vision Enhancement
System, Bausch & Lomb Inc., USA) with 2.2mm incision (Infinity Vision System, Alcon
Laboratories, Inc., USA).
Patients and Methods (1)
• Retrospective Comparative study
• Total Forty seven eyes of 30 patients– 1.8mm Group (Stellaris Group) : 21 eyes– 2.2mm Group (Infinity Group) : 26 eyes
• Cataract grade II or III according to the Lens Opacities Classification System III scale
Patients and Methods (2)
Patients and Methods (3)
• Intraoperative parameters– Total phacoemulsification time
– Cumulative Dissipated Energy (CDE)
• Postoperative parameters– Follow-up at 1 week, 1 month, and 2 months– Best Corrected Visual Acuity (BCVA)– Percentage decrease in endothelial cell density (ECD)– Surgical induced astigmatism (SIA)
Statistical Analysis
• Mann-Whitney Test for comparing two independent groups
• Wilcoxon signed ranks test for comparing before and after operation in the same group
• Significance : P-value less than 0.05
Patients demographics1.8mm Group 2.2mm Group P-value
Eyes 21 26
Age 70.0 (61.0~82.5) 68.0 ( 60.0~74.5) 0.500
Preoperative BCVA (LogMAR)
0.52 (0.30~0.76) 0.30 (0.15~0.57) 0.649
Axial Length (mm)
23.15 (22.35~23.74) 23.84 (22.94~24.65) 0.076
ECD (cells/mm²) 2538.0 (2418.0~1865.0)
2620.5 (2460.5~2828.0)
0.535
CV 43.0 (38.5~50.0) 40.5 (37.8~47.3) 0.346
Hexagonality 51.0 (45.5~55.5) 51.5 (46.8~58.0) 0.847
* Median (Interquartile range)
Phacoemulsification time (sec)
Cumulative Dissipated Energy (CDE)
41.72±17.87
50.30±18.21
P=0.095 P=0.915
• Phacoemulsification time : 1.8 mm Group > 2.2 mm Group• CDE : 1.8 mm Group < 2.2 mm Group → No statistically difference
Visual Acuity (LogMAR)
P=0.102
P=0.131 P=0.520 P=0.358
No statistical difference in BCVA.
EndotheliumMean Endothelial Cell Density (cell/ ㎟ )
PreOP 1month 2months P-value*
1.8mm Group 2626.9±340.4 2116.1±716.2
2453.8±551.1
0.060
2.2mm Group 2706.2±402.9 2278.6±341.0
2324.1±299.2
0.016
P-value† 0.535 0.551 0.525
*: Between Preoperative mean ECD and the value of 2 months after operation at each group.†: Between independent two groups at each follow-up period.
ECD decrement (%) at 2 months after operation ; 1.8mmGroup>2.2mmGroup (P=0.151)
Surgical induced astigmatism• At the 2 months after operation• Vector analysis• 1.8mm Group : 0.46 ± 0.43 Diopters• 2.2mm Group : 0.51 ± 0.47 Diopters• No difference in SIA (P=0.984)
74%
13%13%
62.5%25%
12.5%
Conclusion
• Although not statistically significant, phacoemulsification time tends to take longer and the eyes in which SIA more than 0.5D developed less frequently in 1.8mm Group. – Maybe due to the smaller diameter of phaco tip and incision in
1.8mm MCCS
• We could not find any statistically significant difference in phacoemulsification time, CDE, visual outcome, and SIA between 1.8mm and 2.2mm MCCS.
1.8 mm MCCS is effective as 2.2 mm MCCS